1. Introduction {#sec1}
===============

*Swarnabhasma* (calcined gold) is a traditional *Ayurvedic* medicine for longesubjevity; and treatment of rheumatoid arthritis, diabetes, nervous system disorders, overall body weakness etc. [@bib1], [@bib2], [@bib3], [@bib4]. Complete pharmacokinetics and mechanism of action of *Swarnabhasma* is yet unexplored. It has been hypothesized that gold from *Swarnabhasma* reaches the affected site after oral administration, and possibly releases Au (I) ions in a slow and sustained manner for therapeutic action [@bib1]. When given by sublingual route, Ayurvedic doctors insist that gold gets directly absorbed into blood stream, however there has been no experimental proof regarding this until now [@bib2]. It has been hypothesized previously that some *Swarnabhasma* particles might get absorbed through the sublingual route directly into the blood stream [@bib1]. The present study was conducted to get first evidence about bioavailability of *Swarnabhasma.)*

Little is known about bioavailability of *Swarnabhasma* in human participants. Injectable gold compounds (like gold sodium thiomalate) are fully bioavailable, however only 20--25% gold from Auranofin is absorbed [@bib5], [@bib6]. With this background, present work was initiated to have first report about comparative bioavailability of *Swarnabhasma* given by sublingual and oral route. The maximum dose of *Swarnabhasma* mentioned in the text *Rasatarangini* is 30 mg [@bib7] and in *Rasaratnasamucchay* is 240 mg [@bib8]. The *anupana* specified in the text *Rasaratnasamucchay* [@bib8] is powder of *Maricha* (*Piper nigrum Linn*. ie black pepper) and cow ghee. As the dose of *anupana* is not specified, commonly practiced dose is used in this study. The pilot study was carried out for three doses - 30 mg (sublingually), 30 mg with black pepper powder and ghee (orally); and 240 mg with black pepper and ghee (orally).

2. Materials and methods {#sec2}
========================

The study was conducted on three healthy human participants after obtaining approval from the Institutional Ethics Committee (Reference numbers: BVDUCOA/EC/-186/2013-24 and BVDUCOA/EC/-1553/2015-16). Guidelines of CDSCO (Central Drugs Standard Control Organization, India) were followed for designing the study protocol. The trial was registered with Clinical Trials Registry of India (Reference number -CTRI/2017/10/010135). Written informed consent was obtained from the participants.

2.1. Materials {#sec2.1}
--------------

*Swarnabhasma* manufactured as per classical guidelines [@bib10] by \'Shree Dhootapapeshwar Limited\', Panvel, was used in the study. Dried fruits of Black pepper (*Marich*) and cow ghee were purchased from authentic source in Pune city and tested in certified laboratory (Shickshinny Prasarak Mandali\'s Bhide Foundation, Pune) for compliance with API (Ayurvedic Pharmacopoeia of India) standards. For collection of blood samples, disposable syringes with needles (Dispovan, 2 cc), medicated cotton, disinfectant ethanol and small band-aids were used. For storage of blood prior to analysis, heparinised vacutainers of specification \'BD Vacutainer Sodium heparin^N^ (NH) 75 USP units\' blood collection tubes\' were used. For acid digestion of blood samples, nitric acid and hydrochloric acid of Fisher Scientific (ICP-MS grade) were used. Pipettes (Transferpette brand) were used for transfer of blood from vacutainers to digestion system and Mars 6 model of CEM Corporation was used for acid digestion of blood samples. ICP-MS testing was done using Agilent Technologies 7700 series ICP-MS machine. For accurate weighing of doses, digital balance of \'Shimadzu\' Libror AEG 220 was used.

2.2. Methodology {#sec2.2}
----------------

### 2.2.1. Preparation of doses: {#sec2.2.1}

Black pepper powder was prepared using a clean grinder and sieved by 80 meshes. Just before the trial, dose of 30 mg *Swarnabhasma* was mixed thoroughly with 250 mg black pepper powder and 2.5 gm cow ghee, in a clean dish. Dose of 240 mg was mixed in similar way. A *lehya* (lickable) form thus obtained was made ready for administration. The 30 mg *Swarnabhasma* intended for sublingual administration was kept as it is in powder form.

### 2.2.2. Selection of participants, drug administration and blood sample collection: {#sec2.2.2}

Three healthy young male human participants of upper socioeconomic class, of 27 years of age, residing in Pune city were selected after screening of 30 individuals between age group of 25--35 years as per selection criteria. Screening was done by interview and general check up including *Dashavidha Pariksha.* The selected participants had no signs of acute or chronic illness, and no history of consumption of any gold containing formulations in last 10 years. Their hematological and urine investigations were carried out to rule out abnormalities like anemia, diabetes, infections etc. The participants had not consumed any pharmaceutical medicine, Ayurvedic or of any other medicinal branch since 6 months. All participants were healthy and possessed *tikshna agni,* characterized by ability of digest all types of food. Though particular *Prakriti* was not a selection criterion, it is important to note that all participants had *Kapha-Pitta* as two dominant *doshas* in their *Prakriti*. Females were excluded due to confounding variables associated with hormonal changes with menstrual cycle, pregnancy, lactation etc.

The participants were asked to report in BVMF Ayurveda hospital at 6.30 am, having nil by mouth (NBM) status for 10 h. One blood sample (2 ml) was collected by aseptic technique from cubital vein at 6.45 am, from each participant by disposable syringe. This was labeled as zero hour blood sample. *Swarnabhasma* was administered to the three participants in the doses of 1) 30 mg plain *Swarnabhasma* sublingually, 2) 30 mg mixed with black pepper powder (250 mg)and ghee (2.5 gm) and 3) 240 mg *Swarnabhasma* mixed with black pepper powder (250 mg) and ghee (2.5 gm). 100 ml distilled water was given after 30 min of dose administration and breakfast was given at 9.30 am. No tea or coffee was allowed throughout the experiment, as it may actively interfere with bioavailability. Lunch was provided after completion of experiment.

Blood samples (2 ml each) were withdrawn by aseptic techniques after 1, 2 and 4 h respectively after administration doses of *Swarnabhasma*. The blood samples collected in heparinised vacutainers were stored at −20 °C.

### 2.2.3. Measurement of gold in blood: {#sec2.2.3}

The testing methodology is based on the NIST ---NCL protocol [@bib11] developed for preclinical studies of gold nanoparticles based drug. Frozen blood samples were taken out of the −20 °C freezer and allowed to thaw at room temperature for approximately 2 h. Microwave digestion instrument of Mars 6 model of CEM Corporation was used for acid digestion of blood, which was carried out by addition of 4 ml HNO~3~ and 1 ml HCl to each blood sample followed by digestion as per the protocol [@bib11]. The contents of the vessels (digest) were transferred to a pre weighed 60 ml low density polyethylene (LDPE) bottle. Gold standard of TraceCERT of 100 mg Au/L gold in HCl was used as an internal standard. Digested samples were tested by ICP-MS for gold content.

2.3. Results {#sec2.3}
------------

The observed results were depicted in [Table 1](#tbl1){ref-type="table"} and [Chart 1](#fig1){ref-type="fig"}:Table 1Au levels in blood of three human volunteers after single oral dose of *Swarnabhasma.*Table 1Time - in hours after doseAbsorbance (in μg/l of Au from *Swarnabhasma* (30 mg plain) sublingualAbsorbance (in μg/l) of Au from *Swarnabhasma* (30 mg) with Black pepper powder (250 mg) and ghee (2.5 gm)Absorbance (in μg/l) of Au from *Swarnabhasma* (240 mg) with Black pepper powder (250 mg) and ghee (2.5 gm)000010.7210.8670.59920.9830.580.66840.510.3520.387Chart 1Blood gold concentration versus time profile following single dose administration of *Swarnabhasma* in three doses, 1)30 mg *Swarnabhasma* plain sublingually; 2) 30 mg gold *bhasma* with black pepper (250 mg) and ghee (2.5 gm); and 3) 240 mg *Swarna bhasma* with black pepper (250 mg) and ghee (2.5 gm), in three healthy human participants.Chart 1

Sublingual administration of *Swarnabhasma* in the dose of 30 mg proved to show maximum absorption. *Swarnabhasma* in 30 mg dose given by sublingual route showed T~max~ at 2 h, and C~max~ 0.983 μg/L. *Swarnabhasma* in 30 mg dose with 250 mg black pepper and 2.5 gm ghee showed T~max~ at 1 h and C~max~ 0.867 μg/L. *Swarnabhasma* in 240 mg dose with black pepper and ghee showed T~max~ at 2 h and C~max~ 0.668 μg/L.

3. Discussion {#sec3}
=============

*Swarnabhasma* is a praised ancient drug known for unique actions like rejuvenator, vigor & vitality enhancement and curing debilitating diseases. However there is no adequate evidence about its pharmacology. The pilot study to assess bioavailability of *Swarnabhasma* shows that gold is absorbed at trace levels in blood after a single dose. From 30 mg sublingual dose of *Swarnabhasma,* 0.983 μg/mL gold was detected in systemic circulation at 2 h, which was highest in comparison to other two doses. This may be attributed to the sum of sublingual absorption and also add-on gastric absorption, as the sublingually administered drug is eventually swallowed by the person. It is interesting to note that absorbance of 30 mg oral dose of *Swarnabhasma* was higher than 240 mg, both administered with same amount of black pepper powder and ghee. This may be attributed to better dispersion and separation of agglomerated *bhasma* particles of 30 mg dose in ghee, as compared to 240 mg in same amount of ghee. The linear or non-linear relationship between dose and bioavailability of *Swarnabhasma* has to be established by further research. Comparison of lipoid *anupanas* like ghee and other *anupana* like honey can be carried out in further studies.

The take up of bhasma by sublingual mucosa and gastrointestinal mucosa can be studied further to know the exact mechanism of absorption. Previously a study based on cellular entry of *Swarnabhasma* composed of gold nanoparticles having 60 nm diameter and agglomerated morphology concluded that smaller *bhasma* particles could enter HFF 1 (human foreskin fibroblast) cells via clathrin-dependent receptor-mediated endocytosis, while larger particles may rely more on macropinocuytosis. Few *Swarnabhasma* particles were found in the nucleus, vesicles, cytosol of HFF 1 cells [@bib4]. The mechanisms responsible for actual bioavailability *in* *vivo* is not yet clearly understaood and it needs to be exploreed.

Black pepper is a recommended *anupana* for *Swarnabhasma* [@bib7], which is a proven bioavailability enhancer for many medicaments [@bib12], [@bib13]. In this study it is evident that the absorbance is fastest (T~max~ at 1 h) in case of oral dose of 30 mg *Swarnabhasma* mixed with black pepper powder and ghee, which may be attributable to bioavailability enhancer properties of piperine in black pepper [@bib12], [@bib13]. In this case the absorbed gold appeared in blood circulation after first pass metabolism and was faster than the sublingual absorption.

The chemical composition of investigated *Swarnabhasma* was \>95% gold, along with traces of Fe, Si, Ca, Cu, Mn, Ag, Al, K, Mg, Na, P, Sr, Ti, Zn which was evident by XRD, gravimetric analysis and ICP-AES. Hence it is clear that only traces are absorbed from single dose of *Swarnabhasma*. Gold taken up in systemic circulation (*Rasadhatu* and *Raktadhatu*) may be distributed to rest of the *Dhatus*, may be selectively, as elaborated in Ayurvedic concept of *Khale Kapot Nyaya* (selective uptake of nutrients/medicinal agents by tissues or organs).

The resultant bioavailability of drugs like gold sodium theomalate (100% bioavailable) and Auranofin (20% bioavailable) is attributed to their routes of administration i.e. intravenous and oral respectively. In case of *Swarnabhasma* sublingual route of administration showed maximum bioavailability. Trace level absorption may attribute for the safety and efficacy of *Swarnabhasma*.

*Swarnabhasma* is prescribed in longer durations for rejuvenation. A guideline from *Rasaprakashsudhakar* text states that *Swarnabhasma* should be used in 60 mg dose for 20 years for longevity [@bib14]. There is no experimental evidence of results of long term use however Ayurvedic physicians do come across people those consume *Swarnabhasma* with *Chyavanaprasha* on a daily basis for years and decades. In future studies pharmacokinetics of long term use can be explored.

In this study, estimation of gold levels in blood was carried out by ICP-MS; a sensitive technique for elemental analysis irrespective of what form the element is in. It was possible to analyze total gold levels in blood by this technique. Some other techniques may be adopted to study form of absorbed gold in blood. Presence of gold in components of blood can be checked as a further extension to this study.

In the present study variables like age, sex, *agni*, socio-economic class, demography, *prakriti,* time of dose administration, time and quantity of administration of water, time of food consumption during the study and the food were kept constant as much as possible in all participants. However, the genetic variations, gastric emptying time, daily diet habits, minute variations of *doshas* in *prakriti* were the uncontrolled confounders.

4. Limitations of the study {#sec4}
===========================

This study was carried out in one participant for each dose. It must be noted that we have monitored bioavailability only till 4 h, according to the protocol in single participant for each dose. Just like single case studies, a pilot study of small number of participants can provide preliminary data and state the feasibility of a trial. A single case study helps us to frame questions for more rigorously designed clinical trials [@bib9]. The present study was carried out with same intension.

5. Conclusion {#sec5}
=============

It is indicated from pilot study that gold is absorbed in trace amount from single dose of *Swarnabhasma.* Gold was absorbed in maximum amount from sublingual administration of 30 mg *Swarnabhasma;* and 30 mg dose mixed with black pepper powder and ghee showed quickest absorbance.

Bioavailability study involving adequate participants, assessment for 24 h, and steady state concentration studies of *Swarnabhasma* would yield important conclusions. To explore the concept of Ayurveda, 'potency is seen from the first contact with tissues till the time period it resides in the body' [@bib15], a robust study needs to be undertaken.
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